No Data
No Data
October 31st A-share investment lightning rod | Medikai: Shareholder Fengsheng Jiamei plans to reduce their shareholding by no more than 3%; *Special Treat Ningke: and the actual controller received a notice from the China Securities Regulatory Commission
Hontian shareholders Dawson Investment and Nord Technology plan to reduce their shareholdings by a total of no more than 5%; Meidikai's shareholder Fengsheng Jiamei plans to reduce its shareholding by no more than 3%; Chongqing Iron & Steel incurs a net loss of 1.35 billion yuan in the first three quarters; Risesun Real Estate Development incurs a net loss of 1.425 billion yuan in the first three quarters; Longi Green Energy Technology incurs a net loss of 6.505 billion yuan in the first three quarters; Kraussmaffei incurs a net loss of 1.079 billion yuan in the first three quarters; Ruitai Materials Technology terminates the planned restructuring; ST Ningke and the actual controller received a notice of filing from the China Securities Regulatory Commission.
Hangzhou Medikai Optoelectronics Technology Co., Ltd. Report for the Third Quarter of 2024
MedSci (688079.SH) released its performance for the first three quarters, with a net loss of 64.4378 million yuan.
Meidikai (688079.SH) released the third quarter report for the year 2024, achieving revenue of 3...
There's Reason For Concern Over Hangzhou Mdk Opto Electronics Co.,Ltd.'s (SHSE:688079) Massive 29% Price Jump
Meidikai (688079.SH): plans to launch a stock options and restricted stock incentive plan for 2024.
GeLongHui 27th September | MeidiKai (688079.SH) announced the 2024 stock options and restricted stock incentive plan, which plans to grant a total of 21.4044 million shares/ten thousand units to incentive objects, accounting for approximately 5.33% of the company's total stocks of 401.333334 million shares at the time of the announcement of this incentive plan draft. The exercise price of the stock options granted by this incentive plan (including reserved grants) is 7.37 yuan/share, and the grant price of restricted stocks (including reserved grants) is 3.69 yuan/share.
Meidi Kai (688079.SH): No millimeter wave radar business at the moment.
Mediking (688079.SH) said on the investor interaction platform on September 20th that the company currently has a lidar business and does not have a millimeter-wave radar business. In the future, the company will also conduct research and exploration on more perception layer products, including lidar, millimeter-wave radar, etc., based on the development of the industry.
No Data
No Data